BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29179446)

  • 1. Targeted interference of SIN3A-TGIF1 function by SID decoy treatment inhibits Wnt signaling and invasion in triple negative breast cancer cells.
    Kwon YJ; Leibovitch BA; Bansal N; Pereira L; Chung CY; Ariztia EV; Zelent A; Farias EF; Waxman S
    Oncotarget; 2017 Oct; 8(51):88421-88436. PubMed ID: 29179446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking the PAH2 domain of Sin3A inhibits tumorigenesis and confers retinoid sensitivity in triple negative breast cancer.
    Bansal N; Bosch A; Leibovitch B; Pereira L; Cubedo E; Yu J; Pierzchalski K; Jones JW; Fishel M; Kane M; Zelent A; Waxman S; Farias E
    Oncotarget; 2016 Jul; 7(28):43689-43702. PubMed ID: 27286261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer.
    Bansal N; Petrie K; Christova R; Chung CY; Leibovitch BA; Howell L; Gil V; Sbirkov Y; Lee E; Wexler J; Ariztia EV; Sharma R; Zhu J; Bernstein E; Zhou MM; Zelent A; Farias E; Waxman S
    Oncotarget; 2015 Oct; 6(33):34087-105. PubMed ID: 26460951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive phenotype in triple negative breast cancer is inhibited by blocking SIN3A-PF1 interaction through KLF9 mediated repression of ITGA6 and ITGB1.
    Kadamb R; Leibovitch BA; Farias EF; Dahiya N; Suryawanshi H; Bansal N; Waxman S
    Transl Oncol; 2022 Feb; 16():101320. PubMed ID: 34968869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Insight into the Binding of TGIF1 to SIN3A PAH2 Domain through a C-Terminal Amphipathic Helix.
    He X; Nie Y; Zhou H; Hu R; Li Y; He T; Zhu J; Yang Y; Liu M
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.
    Kwon YJ; Petrie K; Leibovitch BA; Zeng L; Mezei M; Howell L; Gil V; Christova R; Bansal N; Yang S; Sharma R; Ariztia EV; Frankum J; Brough R; Sbirkov Y; Ashworth A; Lord CJ; Zelent A; Farias E; Zhou MM; Waxman S
    Mol Cancer Ther; 2015 Aug; 14(8):1824-36. PubMed ID: 26078298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells.
    Farias EF; Petrie K; Leibovitch B; Murtagh J; Chornet MB; Schenk T; Zelent A; Waxman S
    Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11811-6. PubMed ID: 20547842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Shrivastava S; Jeengar MK; Thummuri D; Koval A; Katanaev VL; Marepally S; Naidu VGM
    Biofactors; 2017 Mar; 43(2):152-169. PubMed ID: 27580587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
    Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
    Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.
    Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS
    Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.
    Wu YM; Chen ZJ; Liu H; Wei WD; Lu LL; Yang XL; Liang WT; Liu T; Liu HL; Du J; Wang HS
    Oncotarget; 2015 Sep; 6(28):25588-601. PubMed ID: 26160845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells.
    Kim S; Lee J; Jeon M; Nam SJ; Lee JE
    Cytokine; 2015 Sep; 75(1):151-8. PubMed ID: 26088755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression.
    Lin D; Kuang G; Wan J; Zhang X; Li H; Gong X; Li H
    Oncol Rep; 2017 Feb; 37(2):895-902. PubMed ID: 27959422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells.
    Taliaferro-Smith L; Oberlick E; Liu T; McGlothen T; Alcaide T; Tobin R; Donnelly S; Commander R; Kline E; Nagaraju GP; Havel L; Marcus A; Nahta R; O'Regan R
    Oncotarget; 2015 Mar; 6(7):4757-72. PubMed ID: 25749031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFβ induced factor homeobox 1 promotes colorectal cancer development through activating Wnt/β-catenin signaling.
    Wang JL; Qi Z; Li YH; Zhao HM; Chen YG; Fu W
    Oncotarget; 2017 Sep; 8(41):70214-70225. PubMed ID: 29050273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agkihpin, a novel SVAE may inhibit the migration and invasion of liver cancer cells associated with the inversion of EMT induced by Wnt/β-catenin signaling inhibition.
    Huang M; Wu S; Hu Q; Wu H; Wei S; Xie H; Sun K; Li X; Fang L
    Biochem Biophys Res Commun; 2016 Oct; 479(2):283-289. PubMed ID: 27644877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular inhibitor of apoptosis protein 2 promotes the epithelial-mesenchymal transition in triple-negative breast cancer cells through activation of the AKT signaling pathway.
    Jo SJ; Park PG; Cha HR; Ahn SG; Kim MJ; Kim H; Koo JS; Jeong J; Park JH; Dong SM; Lee JM
    Oncotarget; 2017 Oct; 8(45):78781-78795. PubMed ID: 29108265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
    Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
    Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer cells through its target GPNMB.
    Okita Y; Kimura M; Xie R; Chen C; Shen LT; Kojima Y; Suzuki H; Muratani M; Saitoh M; Semba K; Heldin CH; Kato M
    Sci Signal; 2017 Apr; 10(474):. PubMed ID: 28400538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.